278 related articles for article (PubMed ID: 20129316)
21. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
[TBL] [Abstract][Full Text] [Related]
22. Memantine treatment of cognitive symptoms in mild to moderate Alzheimer disease: secondary analyses from a placebo-controlled randomized trial.
Pomara N; Ott BR; Peskind E; Resnick EM
Alzheimer Dis Assoc Disord; 2007; 21(1):60-4. PubMed ID: 17334274
[TBL] [Abstract][Full Text] [Related]
23. Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trial.
Doody RS; Ferris SH; Salloway S; Sun Y; Goldman R; Watkins WE; Xu Y; Murthy AK
Neurology; 2009 May; 72(18):1555-61. PubMed ID: 19176895
[TBL] [Abstract][Full Text] [Related]
24. Food for thought: Souvenaid in mild Alzheimer’s disease.
Cummings JL
J Alzheimers Dis; 2012; 31(1):237-8. PubMed ID: 22766771
[No Abstract] [Full Text] [Related]
25. Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one?
Farina E; Mantovani F; Fioravanti R; Pignatti R; Chiavari L; Imbornone E; Olivotto F; Alberoni M; Mariani C; Nemni R
Aging Ment Health; 2006 May; 10(3):211-8. PubMed ID: 16777648
[TBL] [Abstract][Full Text] [Related]
26. Functional ability in executive variant Alzheimer's disease and typical Alzheimer's disease.
Back-Madruga C; Boone KB; Briere J; Cummings J; McPherson S; Fairbanks L; Thompson E
Clin Neuropsychol; 2002 Aug; 16(3):331-40. PubMed ID: 12607146
[TBL] [Abstract][Full Text] [Related]
27. Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study.
Olde Rikkert MG; Verhey FR; Blesa R; von Arnim CA; Bongers A; Harrison J; Sijben J; Scarpini E; Vandewoude MF; Vellas B; Witkamp R; Kamphuis PJ; Scheltens P
J Alzheimers Dis; 2015; 44(2):471-80. PubMed ID: 25322923
[TBL] [Abstract][Full Text] [Related]
28. Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease.
Dubois B; Zaim M; Touchon J; Vellas B; Robert P; Murphy MF; Pujadas-Navinés F; Rainer M; Soininen H; Riordan HJ; Kanony-Truc C
J Alzheimers Dis; 2012; 29(3):527-35. PubMed ID: 22330824
[TBL] [Abstract][Full Text] [Related]
29. Lack of efficacy of hydergine in patients with Alzheimer's disease.
Thompson TL; Filley CM; Mitchell WD; Culig KM; LoVerde M; Byyny RL
N Engl J Med; 1990 Aug; 323(7):445-8. PubMed ID: 2082953
[TBL] [Abstract][Full Text] [Related]
30. Effects of lexical-semantic treatment on memory in early Alzheimer disease: an observer-blinded randomized controlled trial.
Jelcic N; Cagnin A; Meneghello F; Turolla A; Ermani M; Dam M
Neurorehabil Neural Repair; 2012 Oct; 26(8):949-56. PubMed ID: 22460609
[TBL] [Abstract][Full Text] [Related]
31. Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.
Balsis S; Unger AA; Benge JF; Geraci L; Doody RS
Alzheimers Dement; 2012 Jul; 8(4):288-94. PubMed ID: 22465173
[TBL] [Abstract][Full Text] [Related]
32. Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.
Cummings J; Scheltens P; McKeith I; Blesa R; Harrison JE; Bertolucci PH; Rockwood K; Wilkinson D; Wijker W; Bennett DA; Shah RC
J Alzheimers Dis; 2017; 55(3):1131-1139. PubMed ID: 27767993
[TBL] [Abstract][Full Text] [Related]
33. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.
Lloret A; Badía MC; Mora NJ; Pallardó FV; Alonso MD; Viña J
J Alzheimers Dis; 2009; 17(1):143-9. PubMed ID: 19494439
[TBL] [Abstract][Full Text] [Related]
34. Persons with Alzheimer's disease perform daily activities using verbal-instruction technology: a maintenance assessment.
Lancioni G; Singh N; O'Reilly M; Zonno N; Cassano G; De Vanna F; De Bari AL; Pinto K; Minervini M
Dev Neurorehabil; 2010; 13(2):103-13. PubMed ID: 20222771
[TBL] [Abstract][Full Text] [Related]
35. Multistimulation group therapy in Alzheimer's disease promotes changes in brain functioning.
Baglio F; Griffanti L; Saibene FL; Ricci C; Alberoni M; Critelli R; Villanelli F; Fioravanti R; Mantovani F; D'amico A; Cabinio M; Preti MG; Nemni R; Farina E
Neurorehabil Neural Repair; 2015 Jan; 29(1):13-24. PubMed ID: 24788581
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic conversation to improve mood in nursing home residents with Alzheimer's disease.
Tappen RM; Williams CL
Res Gerontol Nurs; 2009 Oct; 2(4):267-75. PubMed ID: 20077983
[TBL] [Abstract][Full Text] [Related]
37. Controlled study on the cognitive and psychological effect of coloring and drawing in mild Alzheimer's disease patients.
Hattori H; Hattori C; Hokao C; Mizushima K; Mase T
Geriatr Gerontol Int; 2011 Oct; 11(4):431-7. PubMed ID: 21518170
[TBL] [Abstract][Full Text] [Related]
38. The impact of supplemental macular carotenoids in Alzheimer's disease: a randomized clinical trial.
Nolan JM; Loskutova E; Howard A; Mulcahy R; Moran R; Stack J; Bolger M; Coen RF; Dennison J; Akuffo KO; Owens N; Power R; Thurnham D; Beatty S
J Alzheimers Dis; 2015; 44(4):1157-69. PubMed ID: 25408222
[TBL] [Abstract][Full Text] [Related]
39. Cognitive rehabilitation as a component of early intervention in Alzheimer's disease: a single case study.
Clare L; Wilson BA; Carter G; Hodges JR
Aging Ment Health; 2003 Jan; 7(1):15-21. PubMed ID: 12554310
[TBL] [Abstract][Full Text] [Related]
40. A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
Remington R; Bechtel C; Larsen D; Samar A; Doshanjh L; Fishman P; Luo Y; Smyers K; Page R; Morrell C; Shea TB
J Alzheimers Dis; 2015; 45(2):395-405. PubMed ID: 25589719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
